This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Company. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Shigeyuki Ando: Innovator in Antifungal Antibiotics
Introduction
Shigeyuki Ando is a notable inventor based in Mitaka, Japan. He has made significant contributions to the field of antifungal antibiotics, particularly through his innovative research and development of novel compounds.
Latest Patents
Ando holds a patent for a polysubstituted thiazolylpyridine carboxyamide antifungal antibiotic. This patent describes a complex of antifungal antibiotic compounds that exhibit in vitro activity against fungi and Gram-positive bacteria. One of the preferred compounds, where R is 4-hydroxypentyl, is denoted as BU-3557B2. The complex is produced by fermenting a culture of Sacchrothrix aerocolonigenes strain N806-4 (ATCC 53712). The recovery process involves adsorption on nonionic porous polymer resin adsorbent. Notably, BU-3557B2 demonstrates in vivo activity against C. albicans vaginal infection, while BU-3557A3, where R is 1,5-dihydroxy-5,5-dimethylpentyl, shows in vivo activity against C. albicans systemic infection.
Career Highlights
Shigeyuki Ando is associated with Bristol-Myers Company, where he has been instrumental in advancing research in antifungal treatments. His work has led to the development of effective compounds that address significant health challenges posed by fungal infections.
Collaborations
Ando has collaborated with notable colleagues, including Maki Nishio and Takeo Miyaki. Their combined expertise has contributed to the successful development of innovative antibiotic solutions.
Conclusion
Shigeyuki Ando's contributions to the field of antifungal antibiotics highlight his role as a key innovator. His patented compounds represent significant advancements in medical science, offering new hope in the fight against fungal infections.